Zonisamide (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Zonisamide drug offered from Glenmark Pharmaceuticals Inc., USA. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Zonisamide |
| SUBSTANCE NAME: | ZONISAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2006-01-30 |
| END MARKETING DATE: | 0000-00-00 |
Zonisamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zonisamide from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2006-01-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-128_6a2eeaef-5d21-4dd5-bcec-9d493b8261f4 |
| PRODUCT NDC: | 68462-128 |
| APPLICATION NUMBER: | ANDA077651 |
Other ZONISAMIDE Pharmaceutical Manufacturers / Labelers:
